Announcement PDF MARKET RELEASE 15 February 2017 Race Oncology Limited TRADING HALT The securities of Race Oncology Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Friday, 17 February 2017, or when the announcement is released to the market. Security Code: RAC Mauro Piccini SENIOR ADVISER, LISTINGS COMPLIANCE (PERTH) ASX Compliance Pty Limited ABN 26 087 780 489 Level 40, Central Park 152-158 St George's Terrace Perth WA 6000 www.asx.com.au Customer service 13 12 79 15 February 2017 Mr Dale Allen ASX Operations Level 40 Central Park 152-158 St George’s Terrace PERTH WA 6000 Via Email Dear Dale TRADING HALT REQUEST In accordance with ASX Listing Rule 17.1, the Company hereby requests that its securities be placed into an immediate trading halt pending an announcement regarding the results of the pre IND meeting with the FDA. The Company requests that trading in its securities be halted until after the expected announcement is made or until the market opens on Friday, 17 February 2017, whichever is the earlier. The Company is not aware of any reason why this trading halt request should not be granted. Yours sincerely Peter Webse Company Secretary Race Oncology Limited, ABN 61 149 318 749 Level 2, 50 Kings Park Road, West Perth WA 6005 www.raceoncology.com